RBMY2CP

RNA expression — cross-omics
Cross-omicsRNA → MUTATIONPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RBMY2CP RNA expression is significantly associated with the mutation status of many other genes, with 39 significant associations in total. PRAD shows the largest number of these associations.

The most reproducible RBMY2CP-associated genes across cancer lineages are ATP8B4, HCN1, and GUCY2F. Each is linked with RBMY2CP in more than 1 cancer types. Because this analysis shows association rather than direction, both RBMY2CP-to-partner and partner-to-RBMY2CP results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (RBMY2CP→partner) and Y-score (partner→RBMY2CP) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
ESCAATP8B4 →+5.303+0.016.001<.00131
ESCAHCN1 →+3.981+0.008.005<.00131
PRADGUCY2F →+7.939+0.029.008<.00131
PRADESRP1 →+7.939+0.029.008<.00131
PRADCLPTM1 →+7.939+0.044.008<.00131
PRADUBTF →+7.939+0.029.008<.00131
Each partner links to its Q-omics profile. Showing the 6 strongest of 39 associations by consensus.

Exploration